Heart FailureDETECT-HFNCT06378632
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
An observational study of Heart Failure, run by Cordio Medical at 45 sites in 3 countries.
Trial summary
Study Design: This is an international, multicenter, observational, non-interventional, prospective, blinded, single-arm, two-period study, to collect patient utterances that will be retrospectively analyzed to determine the sensitivity and UPNR of the HearO system. Read more about this study
- Who is it for?
- Ages 22 years and older
- Conditions the study is for
- Heart Failure
- What is being tested?
- Hearo App
- Type of treatment
- Medical device
- How many people
- 500 participants
- Where
- 45 sitesin 3 countries
- Study dates
- 11 Feb 2022to 15 Jul 2025
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 22 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Outpatient clinics
Major Inclusion Criteria:
- Age 22 or greater
- Diagnosed with Symptomatic Chronic Heart Failure [NYHA II-IVa (ambulatory)]
- At least one of the following:
- One ADHF hospitalization in the last 12 months
- One unplanned IV/SC diuretic administration in the last 6 months
- Two unplanned IV/SC diuretic administrations in the last 12 months
- NTProBNP >500 pg/ml
- Clinically stable HF according to investigator discretion
- Willing to participate as evidenced by signing the written informed consent.
Major Exclusion Criteria:
- Unable to comply with daily use of the App,
- Has had a major cardiovascular event within 3 months prior to enrolment.
- Had a Cardiac Resynchronization Therapy Device (CRT) implanted or upgrading ≤ 1 month prior to screening visit.
- Has estimated Glomerular Filtration Rate (eGFR) < 30 ml/min/1.73.
- Is likely to undergo heart transplantation/ LVAD within 6 months of Screening Visit.
- Was treated for a significant COPD
Trial locations and contacts
45 sites in 3 countries. Contact the study team or a site near you to ask about taking part.
45 sites in 3 countries
United States37 sites, 37 recruiting
- Recruiting
Mission Hospital
Asheville, North Carolina, 28803
Josephine Purbrick, SC, (828) 412-9149, josephine.purbrick@sarahcannon.com
Vinay Thohan, MD
- Recruiting
West Georgia Cardiology
Carrollton, Georgia, 30117
Justina Okeke, SC, (678) 839-7285, justina.okeke@westgacardiology.com
Charlie Rouse, MD
- Recruiting
University of Chicago
Chicago, Illinois, 60637
Veronica Herzog, SC, (773) 834-9794, vherzog@bsd.uchicago.edu
Gene Kim, MD
- Recruiting
Advocate Illinois Masonic Medical Center
Chicago, Illinois, 60657
Maci Eiber, SC, (773) 296-0969, maci.eiber@aah.org
Sorin Danciu, MD
- Recruiting
The Lindner Research Center at The Christ Hospital
Cincinnati, Ohio, 45219
Kathryn Gloria, SC, katherineaubre.glori@thechristhospital.com
Eugene Chung, MD
- Recruiting
Cleveland Clinic
Cleveland, Ohio, 44106
Savi Radesic, (216) 445-6916, radesis@ccf.org
W.H. Wilson Tang, MD
- Recruiting
The Ohio State University
Columbus, Ohio, 43210
Carina Pannelle, (614) 366-8650, carina.panelle@osumc.edu
Rami Kahwash, MD
- Recruiting
Nature Coast Clinical Research
Crystal River, Florida, 34429
Nina Smith, SC, (352) 563-1865, nsmith@encoredocs.com
Susan Pasupuleti, MD
- Recruiting
Advocate Illinois Masonic Health Center
Downers Grove, Illinois, 60515
Debra Heidenreich, SC, (630) 352-2338, debra.heidenreich@aah.org
Sorin Danciu, MD
- Recruiting
St. Elizabeth Healthcare
Edgewood, Kentucky, 41017
Cynthia Mulcahy, SC, (859) 301-4046, cynthia.mulcahy@stelizabeth.com
Haree Vongooru, MD
- Recruiting
Eastern Shore Research Institute
Fairhope, Alabama, 36532
Jessica Huckleberry, SC, (251) 990-1920, jessicahuckleberry@yahoo.com
Michael Pursley, MD
- Recruiting
Moses H. Cone Memorial Hospital
Greensboro, North Carolina, 27401
Michelle McCart, SC, (336) 832-3799, michelle.mccart@conehealth.com
Daniel Bensimhon, MD
- Recruiting
Cardiovascular Institute of the South
Houma, Louisiana, 70360
Kimberly Lirette, SC, (985) 873-5619, kimberly.lirette@cardio.com
Peter Fail, MD
- Recruiting
Jacksonville Center for Clinical Research
Jacksonville, Florida, 32216
Taylor Johnson, SC, (904) 730-0101, tjohnson@encoredocs.com
Michael Koren, MD
- Recruiting
UC San Diego Health
La Jolla, California, 92037
Joshua Gillman, SC, (858) 246-2511, j1gillman@health.ucsd.edu
Nicholas Wettersten, MD
- Recruiting
Cardiovascular Institute of the South
Lafayette, Louisiana, 70503
June Jones, SC, (337) 289-8429, june.jones@cardio.com
Wade May, MD
- Recruiting
Nebraska Heart Center
Lincoln, Nebraska, 68526
Julie Potter, SC, (402) 328-3950, julie.potter@commonspirit.org
Steven Krueger, MD
- Recruiting
VA Loma Linda Healthcare System
Loma Linda, California, 92357
Vicki Simpson, SC, (909) 593-6361, vicki.simpson@va.gov
Jay Patel, MD
- Recruiting
Rio Grande Regional Hospital
McAllen, Texas, 78503
Dina Garcia, SC, (956) 632-6054, dina.garcia2@hcahealthcare.com
Norman Ramirez, MD
- Recruiting
Amavita Clinical Research
Miami, Florida, 33137
Nereisy Alonso, SC, (786) 703-5941, researchadmin@amavita.health
Pedro Martinez Clark, MD
- Recruiting
Advance Medical Research Services Corp (AMRS)
Miami, Florida, 33173
Adam Rachid, SC, (305) 928-8845, arachid.amrs@gmail.com
Yordan Orive Gomez, MD
- Recruiting
Baptist Health (Miami Cardiac & Vascular Institute)
Miami, Florida, 33173
Margie Mckercher, SC, (786) 595-8075, margie.mchercher@baptisthealth.net
Sandra Chaparro, MD
- Recruiting
Midwest Cardiovascular Center
Naperville, Illinois, 60540
Josilyn Klimek, SC, (630) 600-0730, josilyn.klimek@cardio.com
Maria Rosa Costanzo, MD
- Recruiting
Vanderbilt University Medical Center
Nashville, Tennessee, 37232
Terry Weyand, SC, (615) 322-9349, terry.l.weyand@vumc.org
JoAnn Lindenfeld, MD
- Recruiting
University Medical Center New Orleans
New Orleans, Louisiana, 70112
Katasha Washington, SC, (504) 702-4704, katasha.washington@lcmchealth.org
Frank Smart, MD
- Recruiting
Mount Sinai Morningside
New York, New York, 10025
Kathy Idrissi, SC, (646) 561-1170, katharine.idrissi2@mountsinai.org
Kiran Mahmood, MD
- Recruiting
The Mount Sinai Hospital
New York, New York, 10029
Lovelyne Julien, SC, (212) 241-1537, lovelyne.julien@mountsinai.org
Anuradha Lala - Trindade, MD
- Recruiting
VA Southern Nevada Healthcare System
North Las Vegas, Nevada, 89086
Rosalinda Cruz, SC, (702) 791-9000 ext. 15575, Rosalinda.cruz@va.gov
Marriyam Moten, MD
- Recruiting
Comprehensive Medical & Research Center
Plantation, Florida, 33317
Wilmer Santiesteban Garcia, SC, (954) 368-3529, wsantiesteban@compmedical.net
William Korey, MD
- Recruiting
St. Francis Hospital
Roslyn, New York, 11576
Lyn Santiago, SC, (516) 562-6763, lyn.santiago@chsli.org
Rita Jermyn, MD
- Recruiting
St. Johns Center for Clinical Research
Saint Augustine, Florida, 32086
Valerie Hayes, SC, (904) 209-0043, vhayes@encoredocs.com
Ameeth Vedre, MD
- Recruiting
Methodist Hospital of San Antonio
San Antonio, Texas, 78229
Maurene Cantu, (210) 218-4950, maurene.cantu@hcahealthcare.com
Sachin Gupta, MD
- Recruiting
VA San Diego
San Diego, California, 92161
Jonathan Narita, SC, (858) 642-3512, jonathan.narita@va.gov
Nancy Gardetto, MD
- Recruiting
University of California, San Francisco
San Francisco, California, 94117
Priscilla Zhang, SC, (415) 514-7903, priscilla.zhang@ucsf.edu
Liviu Klein, MD
- Recruiting
Kaiser Permanente San Francisco
San Francisco, California, 94118
Priscilla Chung, SC, (415) 833-3480, priscilla.s.chung@kp.org
Jana Svetlichanaya, MD
- Recruiting
Tampa General Hospital
Tampa, Florida, 33606
Kiria Almeida-Tamayo, SC, (813) 844-8058, kalmeidatamayo@tgh.org
Debbie Hoffman, MD
- Recruiting
Robert J. Dole VA Medical Center
Wichita, Kansas, 67218
Deborah Garner, sc, (316) 685-2221 ext. 53352, deborah.garner@va.gov
Freidy Eid, MD
Israel7 sites, 7 recruiting
- Recruiting
University Hospital Samson Assuta Ashdod
Ashdod
Sapir Swisa, SC
Alexander Goldman, MD
- Recruiting
Assuta Be'er Sheva Medical Center
Beersheba
Alex Demitriev, SC
Amos Katz, MD
- Recruiting
Rambam Medical Center
Haifa
Ludmila Helmer, SC, 972-4-7773475
Oren Caspi, MD
- Recruiting
Shaare Zedek Medical Center
Jerusalem
Hadas Barda, SC, 972-2-6666769
Tal Hasin, MD
- Recruiting
Galiee Medical Center
Nahariya
Etti Lasri Kadosh, SC, 972-4-9107747
Shaul Atar, MD
- Recruiting
Tel Aviv Sourasky (Ichilov) Medical Center
Tel Aviv
Tal Fux, SC, 972-3-6972420
Michal Laufer Perl, MD
- Recruiting
Poriya Medical Center
Tiberias
Jannat Mukari, SC, 972-4-6652201
Wadi Kinany, MD
Spain1 site, 1 recruiting
- Recruiting
Hospital Universitari Germans Trias i Pujol
Badalona, 08916
Paloma Gastelurrutia, SC, 0034 930 330 521, pgastelurrutia@gmail.com
Antoni Bayes-Genis, MD
About this study
Official title: An International Multi-center Observational, Single-arm, Blinded Study to Assess the Performance of the Cordio HearO System
Study Design:
This is an international, multicenter, observational, non-interventional, prospective, blinded, single-arm, two-period study, to collect patient utterances that will be retrospectively analyzed to determine the sensitivity and UPNR of the HearO system.
Read the detailed description
Two periods:
Run-In period will be a period in which patients will submit daily recordings, baseline creation
Core period will be a period in which patients will be followed up and will continually submit daily recordings for up-to 24 months per patient or until End-of-Study (EOS), whichever comes first.
- Conditions
- Heart Failure
- Being tested
- Hearo App
- Medical subject headings
- Heart Failure
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Hearo AppDevice
No intervention - only data collection
What is being measured
The primary outcome is the main question the study is designed to answer.
Heart Failure Events (HFEs)
Until the end of the study, each participant will be assigned to one of the following event outcomes:
- Having at least one protocol-defined Heart Failure Event (HFE) in the CORE period
- Having no Heart Failure Event (HFE) during the entire CORE period
Measured: EOS is defined as when a total of at least 78 first usable and CEC-adjudicated HFEs have occurred or up-to 24 months per patient
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Apr 2024
- Study start11 Feb 2022
- Primary completion1 Jul 2025 (estimated)
- Study completion15 Jul 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Heart FailureStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 500 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Cordio Medical
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Ronit Haviv, PhD, Study director, Cordio Medical
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06378632
- Sponsor's protocol ID
- CLN0011 DETECT-HF
- Acronym
- DETECT-HF
- Status last verified
- Mar 2025
- First submitted
- 14 Apr 2024
- Last updated
- 26 Mar 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 26 Mar 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- An International Multi-center Observational, Single-arm, Blinded Study to Assess the Performance of the Cordio HearO System
- ClinicalTrials.gov ID
- NCT06378632
- Acronym / sponsor ID
- DETECT-HF / CLN0011 DETECT-HF
- Conditions
- Heart Failure
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 500 participants (estimated)
- Lead sponsor
- Cordio MedicalIndustry (pharma, biotech, devices)
- Study start
- 11 Feb 2022 (actual)
- Primary completion
- 1 Jul 2025 (estimated)
- Study completion
- 15 Jul 2025 (estimated)
- First posted
- 22 Apr 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Study Design:
This is an international, multicenter, observational, non-interventional, prospective, blinded, single-arm, two-period study, to collect patient utterances that will be retrospectively analyzed to determine the sensitivity and UPNR of the HearO system.
Detailed description
Two periods:
Run-In period will be a period in which patients will submit daily recordings, baseline creation
Core period will be a period in which patients will be followed up and will continually submit daily recordings for up-to 24 months per patient or until End-of-Study (EOS), whichever comes first.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
Who may qualify
- Ages
- 22 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Outpatient clinics
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Hearo AppNo intervention - only data collection | Device | – |
Primary outcome
Heart Failure Events (HFEs)
Time frame: EOS is defined as when a total of at least 78 first usable and CEC-adjudicated HFEs have occurred or up-to 24 months per patient
Until the end of the study, each participant will be assigned to one of the following event outcomes: 1. Having at least one protocol-defined Heart Failure Event (HFE) in the CORE period 2. Having no Heart Failure Event (HFE) during the entire CORE period
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Mar 2025.
- Individual participant dataSharing planned: No
Related trials for Heart Failure
Recruiting
Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes
Heart Failure, Diabetes
RecruitingObservational study
dPmax for Predicting Right Ventricular Failure After Left Ventricular Assist Device Implantation
Ventricular Dysfunction, Right
Active, not recruiting
Comparison of the Balloon-Expandable Edwards Valve and Self-Expandable CoreValve Evolut R or Evolut PRO System for the Treatment of Small, Severely Dysfunctional Surgical Aortic Bioprotheses. The 'LYTEN' Trial
Aortic Valve Stenosis, Regurgitation, Aortic
RecruitingObservational study
Norepinephrine in the Management of General Anesthesia-Induced Arterial Hypotension in Chronic Heart Failure Patients
Hypotension
Enrolling by invitationObservational study
Multi-Scale Analysis of Phenotypes in Heart Failure (MAP-HEART)
Heart Failure
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Ronit Haviv, PhD study director
Cordio Medical
45 sites in 3 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Heart Failure, run by Cordio Medical at 45 sites in 3 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 26 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 45 sites in United States, Israel, Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Bill Tobin ((203) 852-8900, billt@ihcresearch.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Heart Failure Events (HFEs) (time frame: EOS is defined as when a total of at least 78 first usable and CEC-adjudicated HFEs have occurred or up-to 24 months per patient). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Mar 2025.